These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6546975)

  • 1. [Reduction of pre-loading with sublingual molsidomin. Effect on systole-diastole time intervals].
    Romano M; Guerra G; Abita R; Chiariello M
    Minerva Cardioangiol; 1984; 32(1-2):67-71. PubMed ID: 6546975
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemodynamic effects of sublingual molsidomine in patients with or without cardiac failure].
    Rigaud M; Luwaert R; Jouret G; Bardet J; Bourdarias JP
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):523-8. PubMed ID: 6421222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of molsidomine on left ventricular function in coronary heart disease (author's transl)].
    Meyer J; Sprauer R; Krebs W; Erbel R; Schweizer P; Effert S
    Dtsch Med Wochenschr; 1980 Aug; 105(35):1210-6. PubMed ID: 6893579
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute hemodynamic effects of molsidomine in man].
    Tartulier M; Ferrini M; Boutarin J; Ritz B
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):517-21. PubMed ID: 6689394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of molsidomin on the arterial windkessel (author's transl)].
    Sauer G; Tebbe U; Krause H; Kreuzer H; Neuhaus KL
    Z Kardiol; 1981 Sep; 70(9):713-8. PubMed ID: 6895435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of molsidomine on cardiac function in experimental transitory coronary insufficiency].
    Litvitskiĭ PF; Ol'binskaia LI; Sandrikov VA; Aksiuk MA
    Kardiologiia; 1981 Apr; 21(4):71-4. PubMed ID: 6894773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of inotropic drugs on the indices of systolic time intervals and diastolic time intervals (author's transl)].
    Wu BW; LI L; Zhao RR
    Zhonghua Xin Xue Guan Bing Za Zhi; 1979; 7(4):283-6. PubMed ID: 553027
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of Molsidomin on the hemodynamics and working tolerance of patients with angina pectoris].
    Slany J; Mösslacher H; Schmoliner R; Krinik G
    Med Welt; 1976 Dec; 27(49):2396-2400. PubMed ID: 796622
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemodynamic effect of molsidomine in acute administration and as a long-term medication].
    Osterspey A; Jansen W; Tauchert M; Schell U; Fuchs M; Hombach V; Hilger HH
    Med Welt; 1983 Apr; 34(17):523-8. PubMed ID: 6408341
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemodynamic effects of molsidomine.
    Rakovec P
    J Cardiovasc Pharmacol; 1980; 2(6):893-4. PubMed ID: 6160337
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular pharmacology of molsidomine.
    Thulesius O
    Bibl Cardiol; 1984; (38):234-43. PubMed ID: 6398071
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of molsidomine on regional contraction and global function of the left ventricle.
    Stauch M; Haerer W; Rogg-Dussler G; Sigel H; Adam WE
    Am Heart J; 1985 Mar; 109(3 Pt 2):653-8. PubMed ID: 3838402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of the vasodilator molsidomin in the treatment of chronic cardiac insufficiency].
    Mareev VIu; Sazonova LN; Grigor'iants RA; Lobova NM; Irani RM
    Ter Arkh; 1983; 55(9):76-80. PubMed ID: 6688891
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and hemodynamic effect of molsidomine in patients with unstable angina pectoris].
    Beloev I; Tomov I; Elenkova A; Terzieva L
    Vutr Boles; 1982; 21(3):62-9. PubMed ID: 6810552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molsidomine in exertion angina].
    Witchitz S; Kolsky H; Moisson P
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):539-43. PubMed ID: 6689396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of molsidomine on left ventricular dimensions and cardiac function in patients with chronic heart failure.
    Berkenboom GM; Sobolski JC; Vandermoten PP; Stoupel EE; Degre SG
    Am Heart J; 1985 Mar; 109(3 Pt 2):691-3. PubMed ID: 3838405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological basis of therapy with molsidomine].
    Bassenge E
    Herz; 1982 Oct; 7(5):296-306. PubMed ID: 6897544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of aspirin on the hemodynamic effects of molsidomine in healthy volunteers].
    Weber S; de Lauture D; Puechavy C; Pipeau C; Chazelle F; Degeorges M
    Therapie; 1986; 41(3):153-7. PubMed ID: 3529482
    [No Abstract]   [Full Text] [Related]  

  • 19. Haemodynamic effects of molsidomin.
    Karsch KR; Rentrop KP; Blanke H; Kreuzer H
    Eur J Clin Pharmacol; 1978 Jun; 13(4):241-5. PubMed ID: 668780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systolic and diastolic time intervals and mean toxic doses of ethanol].
    Kollár J; Cerenský M; Bodnár S; Bartok D; Berc A
    Bratisl Lek Listy; 1980 Mar; 73(3):339-40. PubMed ID: 7363129
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.